Drugs (Administered) · J9250 · Drug

Methotrexate Sodium, 5 Mg

What Medicare pays for J9250, what providers bill, and how the price varies across 27 states, drawn from CMS 2023 claims data.

$0.18
Medicare pays
$5.21
Providers bill
28.3×
Markup
#1,226 of 9,297
Volume rank

The verdict

Methotrexate Sodium, 5 Mg posts top-quartile national service volume.

Top 13%
national service volume
$0.18
Medicare pays, national avg

Volume percentile ranks this code's national service volume against every tracked procedure; markup percentile ranks its billed-to-Medicare ratio the same way. The same two figures drive both the verdict sentence and the chips above.

According to the Centers for Medicare & Medicaid Services (CMS), the 2023 Medicare Physician & Other Practitioners dataset records payments for 9,297 procedure codes billed across 5,426 hospitals in 56 states and territories; see our methodology for how each figure is sourced and computed.

View my watchlist RSS updates for this procedure
Payment tier in Drugs (Administered)
Lower-paying in category
#495 of 530 procedures in Drugs (Administered) by national average Medicare payment.
Markup tier vs. tracked procedures
28.3x markup
28.3x the Medicare rate. This procedure has too little volume for a reliable catalog-wide rank.
91.2K
Total Services
2.2K
Beneficiaries
824
Providers
27
States with Data

Price Range Across States

Lowest State Avg
$0.14
Washington
Highest State Avg
$0.21
New Mexico

What You Might Pay

Est. Commercial Insurance
$0.53
Range: $0.37 – $0.75
Est. Cash / Self-Pay
$1.61
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

How we estimate these prices

These estimates are based on the RAND Hospital Price Transparency Study (4th Edition, 2024). We map each PlainProcedure category onto a RAND CPT-section bucket (Surgery, Radiology, Pathology and Laboratory, Medicine, Anesthesia, Evaluation and Management) or fall back to the national average when no bucket matches. For Drugs (Administered), the applied ratio is 2.24x Medicare (RAND 2024 national average (2.24x); no matching CPT-section bucket for this category + CMS Medicare baseline). Cash/self-pay estimates blend typical cash discounts (55% of billed charges) with Medicare-based estimates (150% of allowed amounts). These are statistical estimates, not quotes. Contact your insurer or provider for actual costs.

Prices by State

State Medicare Payment Billed Charge
New Mexico $0.21 $1.29
Arizona $0.20 $6.03
District of Columbia $0.20 $0.60
Nevada $0.19 $4.16
Alabama $0.19 $2.45
Rhode Island $0.19 $8.53
Maryland $0.19 $6.16
Virginia $0.19 $3.58
Massachusetts $0.19 $2.75
Texas $0.19 $5.51
New Jersey $0.19 $3.82
Pennsylvania $0.19 $3.16
Louisiana $0.19 $1.58
Florida $0.18 $4.86
Missouri $0.18 $6.88
Nebraska $0.18 $3.81
Connecticut $0.18 $3.30
Illinois $0.18 $4.66
Ohio $0.18 $1.91
Kansas $0.18 $2.98
Tennessee $0.18 $1.88
California $0.18 $12.57
North Carolina $0.18 $1.30
South Carolina $0.17 $6.65
New York $0.16 $4.34
Georgia $0.16 $9.20
Washington $0.14 $14.55

What the Data Says About Methotrexate Sodium, 5 Mg

Across 27 states with reporting providers, CPT code J9250 (Methotrexate Sodium, 5 Mg) shows a national average Medicare payment of $0.18 against an average billed charge of $5.21. That gap, a 28.3x markup, or 2730% above the Medicare allowed amount, is not a meaningful ratio for this low-payment code, so treat the billed figure as a chargemaster reference point rather than a real-world price.

Drugs (Administered) procedures like this one saw 91.2K services billed to Medicare in 2023 by 824 distinct providers, serving 2.2K unique beneficiaries. State-level variation is significant: Washington reports the lowest average payment at $0.14, while New Mexico reports the highest at $0.21. A 51% spread this wide is typically a GPCI story: practice-expense and malpractice-premium components of the fee formula diverge sharply by locality even though the procedure code never changes. Applying the RAND 2024 commercial-to-Medicare ratio for this category (2.24x Medicare; RAND 2024 national average (2.24x); no matching CPT-section bucket for this category + CMS Medicare baseline), the estimated commercial insurance price lands near $0.53, with self-pay cash discounts commonly bringing the figure closer to $1.61. Within Drugs (Administered), Methotrexate Sodium, 5 Mg ranks #495 of 530 tracked procedures by national average Medicare payment.

Where this sits in the registry

Methotrexate Sodium, 5 Mg (J9250) is a CMS 2023 Part B code. These pages keep the volume map and the markup map separate.

  • National volume versus markup on the statistics page, the same two maps as this capsule. Statistics
  • Other Drugs (Administered) codes, ranked by Medicare payment inside the category. Category
  • How volume rank and markup rank are computed. Methodology
  • The full procedures listing in volume order. Procedures

Figures here are CMS averages, not a quote for any patient, plan, or visit.

Frequently Asked Questions

Where does Methotrexate Sodium, 5 Mg rank among Medicare procedures?

According to CMS Medicare Part B claims, Methotrexate Sodium, 5 Mg (CPT J9250) ranks #1,226 of 9,297 procedures by national service volume, the same sort as the procedures listing, and #495 of 530 within Drugs (Administered) by national average Medicare payment. See /methodology#corpus-placement.

How much does Methotrexate Sodium, 5 Mg cost?

Medicare's national average payment for Methotrexate Sodium, 5 Mg (CPT J9250) is $0.18, with providers billing $5.21 on average; state rates run from $0.14 to $0.21, a meaningful but not extreme spread.

Why do providers charge more than Medicare pays?

Providers set their own chargemaster rates (billed charges), which are typically much higher than what any insurer pays. Medicare pays a fixed rate based on the procedure code and geographic location. The billed charge is relevant mainly for uninsured patients, who may face prices closer to the submitted charge.

How much does Methotrexate Sodium, 5 Mg cost with insurance?

With commercial insurance, methotrexate sodium, 5 mg costs an estimated $0.53 on average (range: $0.37-$0.75), a moderate premium over Medicare's $0.18. Without insurance, the estimated cash price is $1.61.

Which state has the lowest cost for Methotrexate Sodium, 5 Mg?

Washington has the lowest average Medicare payment for Methotrexate Sodium, 5 Mg at $0.14, while New Mexico has the highest at $0.21 - a meaningful $0.07 spread.

How many providers perform Methotrexate Sodium, 5 Mg?

A moderate provider base performs Methotrexate Sodium, 5 Mg: 824 providers nationally, totaling 91.2K Medicare-billed services (2.2K beneficiaries) across 27 states in 2023.

What is the billed-to-Medicare markup for Methotrexate Sodium, 5 Mg?

Providers bill 28.3x what Medicare pays for Methotrexate Sodium, 5 Mg - a markup within the typical range at 2730% above the Medicare rate.

Nationwide similar CPT codes

Data-derived peers across the CMS Physician & Other Practitioners extract: nearest national service volume and nearest average Medicare payment. Not clinical substitutes: claim-mass and payment neighborhoods only.

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure

Every figure on PlainProcedure is rendered directly from CMS Medicare Physician & Other Practitioners data, no number is typed in by an editor. This page draws directly on CMS Medicare Physician & Other Practitioners data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.